CVS Health (CVS) is a publicly traded Healthcare sector company. As of July 27, 2026, CVS trades at $107.26 with a market cap of $137.47B and a P/E ratio of 16.55. CVS moved -0.62% today. Year to date, CVS is +34.92%; over the trailing twelve months it is +76.39%. Its 52-week range spans $43.56 to $110.68. Analyst consensus is strong buy with an average price target of $110.56. Rallies surfaces CVS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CVS combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $107.26 |
| Market Cap | $137.47B |
| P/E Ratio | 16.55 |
| EPS | $6.49 |
| Dividend Yield | 0.67% |
| 52-Week High | $110.68 |
| 52-Week Low | $43.56 |
| Volume | 5.70M |
| Avg Volume | 0 |
| Revenue (TTM) | $357.78B |
| Net Income | $8.37B |
| Gross Margin | 39.32% |
17 analysts cover CVS: 0 strong buy, 16 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $110.56.